Skip to main content
Sitemap
About
About INHN
Towards education
Central Office (Cordoba Unit)
INHN Publisher
Programs
Courses
Copyright Policy
How to cite INHN
Website Table of Contents
Last Uploads
Privacy Policy
Search
INHN Legacy website
INHN Projects
Dictionary
Drugs
Photos
Profiles
Interviews with pioneers
Controversies
Discoveries
Books
Biographies
Perspectives
Archives
Ebooks
Collated
Multilingual Project
INHN Publisher
INHN 2013. Edited by Peter R. Martin
Treating the Brain: An Odyssey. By Barry Blackwell. Foreword by Edward Shorter
Enhancer Sensitive Brain Regulations and Synthetic Enhancers (Selegiline, BPAP) Which Counteract the Regressive Effects of Brain Aging By Joseph Knoll
Thomas A. Ban: Lithium in Psychiatry in Historical Perspective
François Ferrero: Psychiatry and Antipsychiatry: Inquiry into the Geneva 1980s’ Psychiatry Crisis.
Johan Schioldann: History of the Introduction of Lithium into Medicine and Psychiatry
Peter R. Martin: Historical Vocabulary of Addiction
Contact
You are here:
INHN
INHN Projects
Perspectives
Gerd Huber and Gisela Gross: The Development of the Psychopathology in Germany in the Last Decades [20th century] with an Introduction by Carlos R. Hojaij
Dictionary
Drugs
Photos
Profiles
Interviews with pioneers
Controversies
Discoveries
Books
Biographies
Perspectives
Thomas A. Ban: A brief historical exchange between Larry Stein and Joseph Knoll
Thomas A. Ban: In historical perspective. Peralta, Cuesta and their Associates findings on the highest familiality of Leonhard’s classification in polynosologic study
Thomas A. Ban: The Ewen Cameron Story.
Thomas A. Ban: The RDoC in historical perspective
Barry Blackwell’s comment on de Leon J, Wise TN, Balon R, Fava G: Dealing with Difficult Medical Colleagues published in Psychotherapy and Psychosomatics
Barry Blackwell: Risk and relevance to lithium usage
Barry Blackwell’s comment (Harvey V. Fineberg: Conflict of Interest: Why Does It Matter? Viewpoint. JAMA 2017; 317: 8)
W. Edwin Fann A History of The Tennessee Neuropsychiatric Institute
Samuel Gershon’s comments on Ronald Pies’ “Do antipsychotics thin the brain?” Journal of Clinical Psychopharmacology 2018; 38 (3): 167- 9.
Samuel Gershon’s comment on Plinio C. Casarotto et al.’s Antidepressant drugs act by directly binding to TRKB neurotrophin receptors.
Samuel Gershon’s comment on Herwig Czech, Gabor S. Ungvari, Kamila Uzarczyk, Paul Wydlow and Gabor Gazdag’s paper on ECT in the shadow of the gas chamber and Gabor Gazdag, Gabor S. Ungvari and Herwig Czech’s paper on Mass killing under the guise of ECT.
Laszlo Gyermek: The role of the tropane skeleton in drug research
Carlos Hojaij’s Comment on Carlos Morra’s “The Mental Status Examination and General Psychopathology, Volume 1, Sensory-perception.”
Carlos R. Hojaij: Ethics for psychiatrists
Gerd Huber and Gisela Gross: The Development of the Psychopathology in Germany in the Last Decades [20th century] with an Introduction by Carlos R. Hojaij
(current)
Edwin Fann’s comments
Carlos Hojaij’s reply to William E. Fann’s comment
Ernst Franzek’s comment
Carlos Hojaij’s reply to Ernst Franzek’s comment
Edward Shorter’s comments
Hector Warnes’ comments
Carlos Hojaij’s reply to Edward Shorter and Hector Warnes
Martin M. Katz’s comment on Jose de Leon’s article “Focusing on drug versus disease mechanisms and on clinical subtyping to advance personalized medicine”
Carl Lange: On periodical depressions and their pathogenesis Speech delivered to the ‘Medical Society of Copenhagen', 19 January 1886
Alex Last: BBC Witness History. The First Antipsychotic Drug. An interview of Thomas Ban.
Carlos Morra: Argentina’s controversial National Law of Mental Health No. 26, 657.
Carlos Morra: The use of human-induced pluripotent stem cells (iPSC) in schizophrenia. Will this technology generate a leap forward in the disease´s modeling?
Carlos Morra: Biomarkers to replace clinical endpoints for the generation of diagnostic hypotheses with the potential to guide the development of novel psychotherapeutic drugs
Carlos Morra: The use of human-induced pluripotent stem cells (iPSC) in schizophrenia. Will this technology generate a leap forward in the disease´s modeling?
Carlos Morra: Review of the modern gene editing techniques: CRISPR-Cas applications in iPSC-derived cultures
Review of the modern gene editing techniques: CRISPR-Cas applications in iPSC-derived cultures (Carlos Morra: Biomarkers to replace clinical endpoints for the generation of diagnostic hypotheses with the potential to guide the development of novel psychot
János Radó’s comment on Lin, Zhang, Feng, et al., “Aliskiren increases aquaporin-2 expression and attenuates lithium-induced nephrogenic diabetes insipidus.”
Janos Radó: Mechanism of Lithium Induced Polyuria in Historical Perspective
Janusz Rybakowski: Emil Kraepelin's dichotomy of “endogenous psychoses” in historical perspective
Mary Seeman’s comment on Jack R. Foucher et al.’s paper on Wernicke-Kleist-Leonhard phenotypes of endogenous psychoses: A review of their validity.
Philip Seeman and Mary V. Seeman: The Dopamine Hypothesis of Schizophrenia in Historical Perspective.
Edward Shorter’s comment on Herwig Czech, Gabor Ungvari, Kamila Uzarzzyk and Gabor Gazdag’s 2020 paper, “Electroconvulsive therapy in the shadow of the gas chamber. Medical innovations and human experimentation in Auschwitz.”
Edward Shorter’s comment on Jack R. Foucher et al.’s paper on Wernicke-Kleist-Leonhard phenotypes of endogenous psychoses: A review of their validity
Hector Warnes’ comment on Despoina Asanaglou et al.’s 2021 paper, “Dopamine regulates pancreatic glucagon and insulin secretion via adrenergic and dopaminergic receptors.”
Hector Warnes’ comment on Silberman, Balon, Starcevic et al “Benzodiazepines: it ́s time to return to the evidence.”
Archives
Ebooks
Collated
Multilingual Project
Gerd Huber and Gisela Gross: The Development of the Psychopathology in Germany in the Last Decades [20th century] with an Introduction by Carlos R. Hojaij
CLICK HERE TO OPEN THE DOCUMENT
May 9, 2019
